Brief: Hims & Hers Health Expands Testosterone Care With Injectable And Oral TRT
Yesterday 13:33
BRIEF-Hims & Hers Health Expands Testosterone Care With Injectable And Oral TRT Oct 21 (Reuters) - Hims & Hers Health, Inc. HIMS.N:
HIMS EXPANDS TESTOSTERONE CARE WITH INJECTABLE AND ORAL TRT
TESTOSTERONE OFFERING SCALING RAPIDLY AS OF Q2 2026
LAUNCHES TWICE-WEEKLY SUBCUTANEOUS INJECTION FOR TESTOSTERONE INCREASE
PROVIDES THREE NEW TESTOSTERONE TREATMENT OPTIONS STARTING TODAY
LAUNCHES WEEKLY INTRAMUSCULAR GENERIC TESTOSTERONE CYPIONATE INJECTION
LAUNCHES FDA-APPROVED KYZATREX ORAL TRT FOR NORMAL TESTOSTERONE IN 90 DAYS
Source text: ID:nBw9lW1x8a
Further company coverage: HIMS.N
((Reutersbriefs@thomsonreuters.com;))
Recent news on Hims & Hers Health
See all newsBrief: Hims & Hers Health Expands Testosterone Care With Injectable And Oral TRT
Hims & Hers Health launches online weight management service for men in Germany
Corrected: US FDA takes step to change peptide compounding policy (Oct 15)
Brief: Hims & Hers Names Jon Franklin As Chief Accounting Officer
Brief: Hims & Hers Names Chief Medical Officers In The Uk And Australia, Deepening Its Investment In Local Clinical Leadership